tiprankstipranks
Vivoryon Therapeutics AG (NL:VVY)
:VVY
Netherlands Market
Want to see NL:VVY full AI Analyst Report?

Vivoryon Therapeutics AG (VVY) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Vivoryon Therapeutics AG’s (VVY) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Vivoryon Therapeutics AG is a Buy.
Vivoryon Therapeutics AG’s (VVY) 20-Day exponential moving average is 1.22, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) 50-Day exponential moving average is 1.27, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.

Vivoryon Therapeutics AG (VVY) Pivot Points

Jun 14, 2026, 02:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.06
1.09
1.13
1.17
1.21
1.24
1.28
Fibonacci
1.09
1.12
1.14
1.17
1.19
1.21
1.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivoryon Therapeutics AG (VVY) Moving Averages

Jun 14, 2026, 02:47 AM
Period
Simple
Exponential
MA5
1.19Sell
1.18Sell
MA10
1.21Sell
1.20Sell
MA20
1.22Sell
1.22Sell
MA50
1.27Sell
1.27Sell
MA100
1.34Sell
1.33Sell
MA200
1.47Sell
1.42Sell
Vivoryon Therapeutics AG’s (VVY) 10-Day exponential moving average is 1.20, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) 100-Day exponential moving average is 1.33, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 50-day simple moving average is 1.27, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 100-day simple moving average is 1.34, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 200-day simple moving average is 1.47, creating a Sell signal.

Vivoryon Therapeutics AG (VVY) Technical Indicators

Jun 14, 2026, 02:47 AM
Name
Value
Implied Action
RSI (14)
35.19
Neutral
STOCH (9,6)
44.60
Neutral
STOCHRSI (14)
40.74
Neutral
MACD (12,26)
-0.03
Buy
ADX (14)
33.93
Neutral
Williams %R
-72.22
Buy
CCI (14)
-206.62
Buy
ATR (14)
0.05
-
Ultimate Oscillator
71.27
Buy
ROC
-6.88
Sell
Vivoryon Therapeutics AG’s (VVY) Relative Strength Index (RSI) is 35.19, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Trend Strength Indicator (ADX) is 33.93, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Commodity Channel Index (CCI) is -206.62, creating a Buy signal.
Vivoryon Therapeutics AG’s (VVY) Price Rate of Change (ROC) is -6.88, creating a Sell signal.

FAQ

Is VVY a Buy, Hold, or Sell?
Based on VVY’s technical indicators, VVY is a Sell.
    What is VVY’s RSI (14)?
    VVY’s RSI (14) is 35.19, which suggests VVY is a Neutral.
      What is VVY’s MACD?
      VVY’s MACD is -0.03, which suggests VVY is a Buy.
        What is VVY’s 5-day moving average?
        VVY’s 5-day moving average is 1.19, which suggests VVY is a Sell.
          What is VVY’s 20-day moving average?
          VVY 20-day moving average is 1.22, which suggests VVY is a Sell.
            What is VVY’s 50-day moving average?
            VVY’s 50-day moving average is 1.27, which suggests VVY is a Sell.
              What is VVY’s 200-day moving average?
              VVY’s 200-day moving average is 1.47, which suggests VVY is a Sell.
                What is VVY’s Williams % R (14)?
                VVY’s Williams % R (14) is -72.22, which suggests VVY is a Buy.
                  What is VVY’s CCI (14)?
                  VVY’s CCI (14) is -206.62, which suggests VVY is a Buy.
                    What is the share price of Vivoryon Therapeutics AG?